This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biomerieux Sa. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Françoise Luciani: Innovator in Hepatitis E Research
Introduction
Françoise Luciani is a notable inventor based in Saint Jean des Vignes, France. He has made significant contributions to the field of hepatitis E research, particularly through his innovative work on polypeptides related to the hepatitis E virus.
Latest Patents
Luciani holds a patent for "Mutated HEV polypeptides and the use thereof for assaying anti-HEV antibodies." This patent involves polypeptides of the p-ORF2 protein of the hepatitis E virus, specifically focusing on the amino acid sequence 394-660. The invention includes mutations of three cysteines at specific positions, which are crucial for determining the presence of antibodies against the hepatitis E virus. The methods outlined in the patent are essential for assessing the humoral response in individuals infected with the virus.
Career Highlights
Throughout his career, Françoise Luciani has worked with prominent companies in the biotechnology sector, including bioMérieux SA and bioMérieux, Inc. His work has been instrumental in advancing diagnostic methods for hepatitis E, contributing to public health initiatives.
Collaborations
Luciani has collaborated with esteemed colleagues, including Yasemin Ataman-Onal and Soizic Daniel, who have supported his research endeavors.
Conclusion
Françoise Luciani's innovative work in the field of hepatitis E research highlights his commitment to advancing medical science. His contributions through patents and collaborations continue to impact the understanding and diagnosis of hepatitis E.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile